bioXXmed AG (T5O) Stock Price & News

All values in EUR	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Revenue	1.75K	1.75K	8.50K	8.50K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.12K	3.12K	6.50K	6.50K
Operating expense	256.48K	256.48K	138.00K	138.00K
Total operating expenses	256.48K	256.48K	138.00K	138.00K
Operating income	-254.73K	-254.73K	-129.50K	-129.50K
Other non operating income	1.56K	1.56K	3.00K	3.00K
EBT including unusual items	-317.42K	-317.42K	-128.00K	-128.00K
EBT excluding unusual items	-253.16K	-253.16K	-128.00K	-128.00K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	253.33K	253.33K	85.00K	85.00K
Net income	-317.42K	-317.42K	-128.00K	-128.00K
Net profit margin	-18,169.15%	-18,169.15%	-1,505.88%	-1,505.88%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-1.50K	-1.50K
Net interest expenses	-	-	-1.50K	-1.50K
Depreciation and amortization charges	22.00	22.00	46.50K	46.50K
EBITDA	-254.71K	-254.71K	-129.48K	-129.48K
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance